ClinicalTrials.Veeva

Menu

Home-visits From geRiatric tEam aFter hIp fracTure (REFIT)

H

Herlev Hospital

Status

Unknown

Conditions

Geriatric Assessment
Hip Fractures
Old Age; Atrophy
Frailty

Treatments

Other: Control group, no designated follow up
Other: Home visit and comprehensive geriatric assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT04777136
HgH_UGT_01

Details and patient eligibility

About

The primary objective is to examine the effect of multidisciplinary geriatric team home-visits as follow-up after a hip fracture in old patients. The hypothesis is that home-visits will reduce the number of falls, readmissions, prevent functional decline, optimize that medical treatment, and a higher degree of satisfaction and quality of life.

Full description

Among older individuals, falling is a strong predictor of frailty, morbidity, and mortality and may cause a fracture. Many older patients experience recurrent falls, further functional decline, and readmission within the first three months. Hence, fall-related visits to the hospital represent a "red flag" but are also an opportunity for targeted intervention and prevention of future falls. However, many older patients are only treated for fall-related injuries and discharged without fall risk assessment or evaluation, hence there is a need for follow-up with targeted fall assessment and intervention to prevent further falls.

Thus, the present project aims to examine the effect of home-visit follow-up of older frail patients discharged from the orthopedic ward with a hip fracture. Furthermore, we will explore the effect of a cross-sectorial collaboration between hospital and municipality in the patients' homes to prevent falls, readmissions, medicine-associated adverse effects, and physical deconditioning in old frail patients.

The present study is a interventional trial. The intervention will consist of a home visit within ten weekdays of the discharge, where a comprehensive geriatric assessment (CGA) will be performed. The team performing the CGA consist of a Geriatrician and an experienced geriatric nurse. CGA is an overall assessment of the patient taking account of; the presence and severity of comorbidity, the nutritional state, cognitive and functional status, review of current medications, and social measures. The purpose is to stabilize and optimize current as well as chronic conditions, and reduce the probability of adverse events and falls, and to secure interventions or changes persist through the transition from the secondary to the primary health care system. The assessment may lead to several interventions, including; medicine review (new medicine, change in current or discontinuation), initiation of a nutritional effort or contact to a dietitian, referral to other health care services (outpatient clinics, hospitals, or general practitioner), referral to physiotherapy and/or occupational therapy or optimization of home care.

Patients randomized to the control group will receive standard care, where the subsequent need for medical service or increased home care will require contact with the general practitioner or the municipality, at the patient's initiative.

Enrollment

200 patients

Sex

All

Ages

70 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 70 years or older
  • Hip fracture
  • Ability to provide informed consent
  • Residence in one of three following municipalities: Gladsaxe, Rudersdal or Lyngby-Taarbæk

Exclusion criteria

  • No ability to provide informed consent
  • Patients, who dies within 48 hours of discharge
  • Terminal patients

Nursing home residents

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Geriatric home visit
Experimental group
Description:
Home-visit where a comprehensive geriatric assessment will be performed
Treatment:
Other: Home visit and comprehensive geriatric assessment
Standard care
Active Comparator group
Description:
No follow-up.
Treatment:
Other: Control group, no designated follow up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems